Manhattan Scientifics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MHTX research report →
Price Chart
About the company
Manhattan Scientifics, Inc. operates as an innovation hub, primarily dedicated to the advancement and market introduction of technologies designed to enhance human life across the United States. The company's specialized efforts are concentrated within the fields of nanotechnology and nanomedicine.
- CEO
- Emmanuel Tsoupanarias
- IPO
- 1998
- Employees
- 1
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on MHTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $55.93K
- P/E
- -0.05
- PEG
- 0.01
- P/S
- 0.00
- P/B
- -0.03
- EV/EBITDA
- -0.04
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 66.63%
- ROIC
- 40.36%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-1,000-102.0%
- Op Income
- $-703,000
- Net Income
- $-1,165,000+57.3%
- EPS
- $-0.00+57.1%
- OCF Growth
- +45.6%
- FCF Growth
- +45.6%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 9.61
- RSI (14)
- 62
- Avg Volume
- 4.81K
No earnings-call transcripts are available for MHTX yet.
- Free Float
- 84.8%
- Shares Outstanding
- 559.28M
- Float Shares
- 474.16M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| City National Bank | 70.00K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 16 | Theoharis Chris | other | 500,000 |
| Jun 30, 15 | Theoharis Chris | other | 500,000 |
| Jun 30, 16 | SCHATZ LARRY H | other | 500,000 |
| Jun 30, 15 | SCHATZ LARRY H | other | 500,000 |
| Jun 30, 16 | Friedman Leonard | other | 500,000 |
| Jun 30, 15 | Friedman Leonard | other | 500,000 |
| Jun 30, 15 | Georgiou Photios Frank | other | 500,000 |
| Jun 30, 16 | Georgiou Photios Frank | other | 500,000 |
| Sep 24, 15 | Theoharis Chris | buy | 20,000 |
| Jun 30, 15 | Theoharis Chris | other | 500,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MHTX coverage
Recent articles, reports, and earnings notes.
No research on MHTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MHTX report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.